Yatharth Hospital [YATHARTH] vs Indraprastha Medical [INDRAMEDCO] Detailed Comparison

Yatharth Hospital
NSE
Loading...

Indraprastha Medical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Yatharth Hospital wins in 6 metrics, Indraprastha Medical wins in 11 metrics, with 0 ties. Indraprastha Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Yatharth Hospital | Indraprastha Medical | Better |
---|---|---|---|
P/E Ratio (TTM) | 43.82 | 26.86 | Indraprastha Medical |
Price-to-Book Ratio | 3.52 | 7.26 | Yatharth Hospital |
Debt-to-Equity Ratio | 0.71 | 5.49 | Yatharth Hospital |
PEG Ratio | N/A | 188.78 | N/A |
EV/EBITDA | 23.33 | 16.54 | Indraprastha Medical |
Profit Margin (TTM) | 14.83% | 11.87% | Yatharth Hospital |
Operating Margin (TTM) | 19.05% | 15.10% | Yatharth Hospital |
EBITDA Margin (TTM) | 19.05% | 15.10% | Yatharth Hospital |
Return on Equity | 10.40% | 29.97% | Indraprastha Medical |
Return on Assets (TTM) | 7.41% | 15.87% | Indraprastha Medical |
Free Cash Flow (TTM) | $-1.61B | $1.20B | Indraprastha Medical |
Dividend Yield | N/A | 1.13% | N/A |
1-Year Return | 36.33% | 69.72% | Indraprastha Medical |
Price-to-Sales Ratio (TTM) | 6.98 | 3.44 | Indraprastha Medical |
Enterprise Value | $51.37B | $40.41B | Yatharth Hospital |
EV/Revenue Ratio | 5.84 | 2.98 | Indraprastha Medical |
Gross Profit Margin (TTM) | 9.83% | 36.13% | Indraprastha Medical |
Revenue per Share (TTM) | $99 | $148 | Indraprastha Medical |
Earnings per Share (Diluted) | $14.56 | $17.57 | Indraprastha Medical |
Beta (Stock Volatility) | N/A | 0.60 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Yatharth Hospital vs Indraprastha Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Yatharth Hospital | -0.92% | 0.17% | 19.21% | 28.69% | 47.81% | 8.24% |
Indraprastha Medical | -2.05% | -5.91% | 11.20% | 13.92% | 10.18% | -15.30% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Yatharth Hospital | 36.33% | 90.85% | 90.85% | 90.85% | 90.85% | 90.85% |
Indraprastha Medical | 69.72% | 682.91% | 716.95% | 568.14% | 904.03% | 928.72% |
Performance & Financial Health Analysis: Yatharth Hospital vs Indraprastha Medical
Metric | YATHARTH | INDRAMEDCO |
---|---|---|
Market Information | ||
Market Cap | ₹61.47B | ₹46.64B |
Market Cap Category | Mid cap | Small cap |
10 Day Avg. Volume | 523,672 | 161,824 |
90 Day Avg. Volume | 506,087 | 364,490 |
Last Close | ₹626.85 | ₹458.85 |
52 Week Range | ₹345.60 - ₹693.00 | ₹246.15 - ₹572.00 |
% from 52W High | -9.55% | -19.78% |
All-Time High | ₹693.00 (Nov 04, 2024) | ₹572.00 (Jan 06, 2025) |
% from All-Time High | -9.55% | -19.78% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.36% | 0.06% |
Quarterly Earnings Growth | 0.01% | 0.32% |
Financial Health | ||
Profit Margin (TTM) | 0.15% | 0.12% |
Operating Margin (TTM) | 0.19% | 0.15% |
Return on Equity (TTM) | 0.10% | 0.30% |
Debt to Equity (MRQ) | 0.71 | 5.49 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹181.20 | ₹65.04 |
Cash per Share (MRQ) | ₹58.10 | ₹35.07 |
Operating Cash Flow (TTM) | ₹1.50B | ₹1.57B |
Levered Free Cash Flow (TTM) | ₹-1,552,484,992 | ₹1.19B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 1.13% |
Last 12-Month Dividend | N/A | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Yatharth Hospital vs Indraprastha Medical
Metric | YATHARTH | INDRAMEDCO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 43.82 | 26.86 |
Forward P/E | 25.95 | 188.78 |
PEG Ratio | N/A | 188.78 |
Price to Sales (TTM) | 6.98 | 3.44 |
Price to Book (MRQ) | 3.52 | 7.26 |
Market Capitalization | ||
Market Capitalization | ₹61.47B | ₹46.64B |
Enterprise Value | ₹51.37B | ₹40.41B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.84 | 2.98 |
Enterprise to EBITDA | 23.33 | 16.54 |
Risk & Other Metrics | ||
Beta | N/A | 0.60 |
Book Value per Share (MRQ) | ₹181.20 | ₹65.04 |
Financial Statements Comparison: Yatharth Hospital vs Indraprastha Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | YATHARTH | INDRAMEDCO |
---|---|---|
Revenue/Sales | ₹2.32B | ₹3.34B |
Cost of Goods Sold | ₹2.09B | ₹2.13B |
Gross Profit | ₹227.85M | ₹1.21B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹441.63M | ₹504.10M |
EBITDA | ₹623.73M | ₹676.70M |
Pre-Tax Income | ₹485.31M | ₹552.70M |
Income Tax | ₹98.08M | ₹142.60M |
Net Income (Profit) | ₹387.23M | ₹410.10M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | YATHARTH | INDRAMEDCO |
---|---|---|
Cash & Equivalents | ₹3.62B | ₹614.80M |
Total Current Assets | ₹8.56B | ₹4.31B |
Total Current Liabilities | ₹845.77M | ₹1.79B |
Long-Term Debt | ₹53.30M | ₹305.40M |
Total Shareholders Equity | ₹16.37B | ₹5.97B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹5.00B | ₹3.27B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | YATHARTH | INDRAMEDCO |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | YATHARTH | INDRAMEDCO |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 523,672 | 161,824 |
Average Daily Volume (90 Day) | 506,087 | 364,490 |
Shares Outstanding | 96.35M | 91.67M |
Float Shares | 33.98M | 41.02M |
% Held by Insiders | 0.63% | 0.58% |
% Held by Institutions | 0.12% | 0.03% |
Dividend Analysis & Yield Comparison: Yatharth Hospital vs Indraprastha Medical
Metric | YATHARTH | INDRAMEDCO |
---|---|---|
Last 12-Month Dividend | N/A | ₹4.50 |
Last 12-Month Dividend Yield | N/A | 1.13% |
3-Year Avg Annual Dividend | N/A | ₹3.33 |
3-Year Avg Dividend Yield | N/A | 2.17% |
3-Year Total Dividends | N/A | ₹10.00 |
Ex-Dividend Date | N/A | Sep 13, 2024 |